K. Kajiwara et al., ATHEROGENIC LIPOPROTEINS INHIBIT CATECHOLAMINE SECRETION IN CULTURED BOVINE ADRENAL-MEDULLARY CELLS, Naunyn-Schmiedeberg's archives of pharmacology, 358(3), 1998, pp. 308-314
The effects of lipoproteins on ion channel-mediated catecholamine secr
etion were investigated in cultured bovine adrenal medullary cells. Lo
w density lipoprotein (LDL, 20-80 mg/dl) and lipoprotein(a) [Lp(a); 10
-80 mg/dl] inhibited catecholamine secretion induced by carbachol, an
activator of nicotinic acetylcholine receptor-ion channels. LDL and Lp
(a) suppressed carbachol-induced Na-22(+) influx as well as Ca-45(2+)
influx in a concentration-dependent manner similar to that of catechol
amine secretion. The inhibition of catecholamine secretion by Lp(a) wa
s not overcome by increasing the concentration of carbachol. On the ot
her hand, high density lipoprotein (HDL; <150 mg/dl) had no effect on
Na-22(+) influx, Ca-45(2+) influx, and catecholamine secretion. Like L
DL and Lp(a), a synthetic peptide homologous to human plasma apolipopr
otein B (apoB), apoB fragment(3358-3372)-amide (3-60 mu M), attenuated
Na-22(+) influx, Ca-45(2+) influx, and catecholamine secretion caused
by carbachol. The apoB fragment also suppressed Na-22(+) influx induc
ed by veratridine tan activator of voltage-dependent Na+ channels) and
Ca-45(2+) influx induced by 56 mM K+ tan indirect activator of voltag
e-dependent Ca2+ channels). These findings suggest that atherogenic li
poproteins such as LDL and Lp(a) suppress catecholamine secretion by i
nterfering with Naf influx through nicotinic acetylcholine receptor-io
n channels, in which apoB, a structural component common to both LDL a
nd Lp(a), plays an important role. The inhibition by atherogenic lipop
roteins of catecholamine secretion may influence the progression of at
herosclerosis induced by these lipoproteins.